Butterfly Network

Butterfly Network Competitive Intelligence & Landscape

butterflynetwork.com ·

Butterfly Network
ForesightIQ Predictions

What is Butterfly Network likely to do next?

ForesightIQ connects Butterfly Network's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.

Hiring signal

Senior hiring patterns point to a planned enterprise product line launching within two quarters.

High confidence · Next 1–2 quarters
Product signal

Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.

Likely · Next quarter
Market signal

Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.

Plausible · Next 2–3 quarters
Butterfly Network Unlock Butterfly Network's predicted moves

Free · generated in ~60 seconds · no signup to preview

Overview

Butterfly Network Overview

Butterfly Network (butterflynetwork.com) is a pioneering digital health company dedicated to democratizing medical imaging by making high-quality ultrasound accessible and affordable globally [ir.butterflynetwork.com/overview/default.aspx]. Founded by Jonathan M. Rothberg, the company’s core mission is to enable universal access to superior medical imaging, contributing to global health equity [ir.butterflynetwork.com/overview/default.aspx].

Butterfly Network transforms point-of-care ultrasound (POCUS) by integrating whole-body probes with advanced AI, workflow management software, and a comprehensive education suite [butterflynetwork.com].

The company's flagship products include the Butterfly iQ3, their third-generation probe with double the processing power and clearer images, and the iQ+, a second-generation single-probe, whole-body imaging device [butterflynetwork.com].

Butterfly Network also offers application-specific probes like Butterfly Move, iQ+ Bladder™, and iQ3 Vet™, alongside software and services such as Compass AI™ for integrated ultrasound program management and an AI Marketplace [butterflynetwork.com]. These solutions are designed to empower clinicians across various specialties including anesthesiology, cardiology, emergency medicine, OB/GYN, and veterinary care, as well as for use in health systems and educational programs [butterflynetwork.com].

Butterfly Network serves over 145,000 customers worldwide, elevating patient care through its innovative technology [butterflynetwork.com]. The company's headquarters are located in Burlington, Mass., and New York, NY, and it was publicly listed on the NYSE in November 2020 through a merger with Longview Acquisition Corp. [ir.butterflynetwork.com/News/press-releases/news-details/2025/Butterfly-Network-Named-to-TIMEs-List-of-the-Worlds-Top-HealthTech-Companies-2025/default.aspx, butterflynetwork.com/press-releases/merger-longview]. Led by President, Chief Executive Officer, and Chairman of the Board Joseph DeVivo, Butterfly Network is driven by a purpose to build the future of healthcare through bold thinking, problem-solving, and innovation in medical imaging [ir.butterflynetwork.com/governance/executive-management/default.aspx, butterflynetwork.com/careers].

Competitors

Butterfly Network Competitors

Butterfly Network, a leader in point-of-care ultrasound (POCUS), faces competition from various companies offering portable ultrasound devices and AI-powered diagnostic tools. One significant competitor is Exo, which modernizes medical imaging through its ultrasound platform and artificial intelligence, operating in the healthcare technology sector. Similar to Butterfly Network, Exo provides portable ultrasound devices and AI tools to assist healthcare professionals in medical imaging, positioning itself as a direct rival in the rapidly evolving POCUS market. Both companies aim to integrate advanced technology into clinical assessments, diagnoses, and treatments, with Exo's offerings competing directly with Butterfly Network's whole-body probes and AI-driven software.

Another key competitor is Clarius Mobile Health Corp., which also specializes in handheld ultrasound devices. Like Butterfly Network, Clarius offers portable solutions that integrate with mobile devices, focusing on flexibility and accessibility in medical imaging. The competition between Butterfly Network and Clarius often centers on the portability, image clarity, and user experience of their respective handheld ultrasound systems. Both companies cater to a broad range of medical specialties, aiming to empower clinicians with on-demand imaging capabilities.

GE HealthCare is a formidable competitor, particularly with its Vscan Air. While Butterfly Network emphasizes its compact, single-probe, whole-body imaging device and Ultrasound-on-Chip™ technology, GE HealthCare leverages its extensive experience and market presence in medical imaging to offer competitive portable ultrasound solutions. GE HealthCare's offerings often target a similar market of clinicians and health systems seeking integrated ultrasound platforms, and their solutions are known for reliability and established support networks.

AISAP distinguishes itself by focusing on FDA-cleared diagnostic algorithms embedded in an AI operating system compatible with any POCUS device, including Butterfly Network's. Rather than developing its own hardware, AISAP offers a POCUS OS™—an all-in-one platform that integrates seamlessly with existing ultrasound devices. This approach positions AISAP as a competitor in the software and AI-driven diagnostics space, offering solutions that enhance the capabilities of various ultrasound systems, potentially including Butterfly Network's probes. This contrasts with Butterfly Network's integrated hardware and software ecosystem, as AISAP provides an agnostic software layer.

Other notable competitors include Philips with its Lumify system and Echolight, which also specializes in portable ultrasound technologies. These companies, like Butterfly Network, emphasize the benefits of compact, accessible ultrasound for various medical applications. While Butterfly Network highlights its advanced AI, workflow management software, and comprehensive education suite, these competitors also offer their unique advantages in terms of features, pricing structures, and market penetration, making the point-of-care ultrasound market highly dynamic and competitive.

Alternatives

Butterfly Network Alternatives

Product & Pricing

Butterfly Network Product and Pricing Intelligence

Butterfly Network (butterflynetwork.com) offers advanced point-of-care ultrasound (POCUS) solutions, featuring its whole-body probes and comprehensive software. The company's flagship products include the iQ3 and iQ+ probes. The iQ3, an award-winning third-generation probe, is priced at $3,899, boasting double the processing power and clearer images. The iQ+, a second-generation single-probe, whole-body imaging device, is available for $2,699 [https://www.butterflynetwork.com/pricing]. These probes integrate seamlessly with AI, workflow management software, and an extensive education suite, aiming to transform patient care by empowering clinicians with accessible ultrasound capabilities.

A required Butterfly membership unlocks the full potential of these devices, serving as a user license and providing access to the Butterfly iQ app and probe functionality [https://support.butterflynetwork.com/s/article/16910589662491-Membership]. Two primary membership tiers are offered: a $299/year option and a $420/year option [https://www.butterflynetwork.com/pricing]. Both tiers support a maximum of two probes and include essential features like M-Mode & Color Doppler. The higher-tier $420/year membership further enhances the experience with access to over 20 clinical applications, unlimited cloud storage, and on-demand educational videos, including content from the Butterfly Academy™, a curated library of ultrasound courses developed by in-house POCUS experts [https://www.butterflynetwork.com/pricing].

Butterfly Network frequently provides promotional offers to make its technology more accessible. Clinicians can save up to $450 instantly or up to $900 with a demo of their all-in-one probes [https://www.butterflynetwork.com/]. Additionally, the company offers trade-in programs, allowing customers to receive up to $1,500 credit towards an iQ3 when trading in a Butterfly iQ or iQ+ device [https://www.butterflynetwork.com/index.html]. These pricing strategies and bundled offerings underscore Butterfly Network's commitment to delivering a complete and integrated POCUS solution for various medical specialties and use cases, from individual clinicians to large health systems.

Hiring & Layoffs

Butterfly Network Hiring and Layoffs

Butterfly Network (butterflynetwork.com) is actively expanding its team, signaling a robust growth strategy focused on innovation in medical imaging. The company consistently invites individuals to join their mission of building the future of healthcare, describing their team as "bold thinkers, problem-solvers, and innovators driving a digital revolution in medical imaging" [butterflynetwork.com/careers]. This open call for talent suggests a continuous and proactive recruitment drive to support its ambitious goals, rather than sporadic hiring. Prospective employees are encouraged to "See open roles" on their careers page, indicating a variety of available positions across different departments [butterflynetwork.com/careers].

Recent announcements and developments further illustrate Butterfly Network's strategic hiring patterns. For instance, the company recently appointed Arun Nagdev, MD, as Chief Medical Officer – POCUS, and David Horsley as Senior Vice President, Innovation – Butterfly Embedded™ in March and April 2026, respectively [butterflynetwork.com/press]. These high-profile appointments in critical areas like POCUS (point-of-care ultrasound) and embedded ultrasound technology underscore a clear investment in leadership and specialized expertise. Such strategic hires align with their focus on advanced AI, workflow management software, and a comprehensive education suite, as highlighted on their homepage [butterflynetwork.com/].

The company's emphasis on "Ultrasound-on-Chip™ technology" and its mission to "democratize medical imaging" globally suggests a need for diverse talent, from engineers and software developers to medical professionals and sales representatives [ir.butterflynetwork.com/overview/default.aspx]. The development of the Software Development Kit (SDK) for custom app creation also points to a demand for developers to expand the Butterfly Garden and AI Marketplace [butterflynetwork.com/ai-developers]. Currently, there is no public information or press releases indicating any significant layoffs at Butterfly Network, reinforcing a stable and growth-oriented hiring environment. The consistent messaging across their career pages and press releases paints a picture of a company in an active expansion phase, strategically hiring to solidify its position as a leader in point-of-care ultrasound.

Leadership

Butterfly Network Management and Leadership Team

The leadership at Butterfly Network (butterflynetwork.com) is helmed by Joseph DeVivo, who serves as the President, Chief Executive Officer, and Chairman of the Board. Mr. DeVivo brings extensive experience, with over two decades in business leadership within the digital health sector, focusing on portable, semiconductor-based ultrasound technology and intuitive software solutions [https://ir.butterflynetwork.com/governance/executive-management/default.aspx].

The executive management team includes several key individuals driving the company's strategic initiatives.

Steve Cashman holds the position of EVP, Chief Business Officer, overseeing global sales, marketing, product, and corporate strategy to advance Butterfly Network's mission of democratizing medical imaging worldwide [https://ir.butterflynetwork.com/governance/board-of-directors/person-details/default.aspx?ItemId=d18d3777-8d7c-4ed1-9134-5bada5cf77dd].

John Doherty was appointed as Executive Vice President, Chief Financial Officer, effective December 8, 2023 [https://ir.butterflynetwork.com/News/press-releases/news-details/2025/Butterfly-Network-Appoints-John-Doherty-as-Chief-Financial-Officer/default.aspx].

Megan Carlson is the SVP, Accounting & Finance - Chief Accounting Officer [https://ir.butterflynetwork.com/governance/executive-management/default.aspx].

Further strengthening the leadership team are several Senior Vice Presidents.

Victor Ku leads the global technology strategy, product development, and innovation roadmap as the SVP, Chief Technology Officer, leveraging over two decades of experience in semiconductor-based imaging and AI-enabled analytics [https://ir.butterflynetwork.com/governance/board-of-directors/person-details/default.aspx?ItemId=643365e4-9034-4b2e-ae44-89e7603cdaa7].

John Soto serves as SVP, International, responsible for all international revenue-generating activities [https://ir.butterflynetwork.com/governance/board-of-directors/person-details/default.aspx?ItemId=7af7caf3-8ddd-4193-b2b2-65ff0ab45f1d], while Jason Heim is the SVP, US Sales, leading domestic commercial strategy [https://ir.butterflynetwork.com/governance/board-of-directors/person-details/default.aspx?ItemId=c76deb3a-1271-4779-9765-69f0d02c2784]. Additionally, Katie Gowryluk is the VP, Chief of Staff, playing a crucial role in strategic execution and organizational alignment [https://ir.butterflynetwork.com/governance/board-of-directors/person-details/default.aspx?ItemId=0f1acdac-9e85-415d-898c-62159edbc253].

Financials

Butterfly Network Financial Performance, Fundraising, M&A

Butterfly Network (butterflynetwork.com), a digital health company specializing in semiconductor-based ultrasound devices and AI-powered software, has demonstrated consistent growth in its financial performance. The company reported first-quarter revenue of $26.5 million in 2026, marking a 25% year-over-year increase, alongside a gross margin of 69% and an adjusted EBITDA of ($6.1 million) [https://ir.butterflynetwork.com/News/press-releases/news-details/2026/Butterfly-Network-Reports-First-Quarter-2026-Financial-Results/default.aspx]. This follows a record-breaking fourth quarter in 2025, where Butterfly Network achieved $31.5 million in revenue, a 41% year-over-year growth, and generated positive net cash flow of $6.3 million [https://ir.butterflynetwork.com/News/press-releases/news-details/2026/Butterfly-Network-Reports-Fourth-Quarter-2025-Financial-Results/default.aspx]. The company's 2025 financial year also saw a third-quarter revenue of $21.5 million, a 5% year-over-year increase, with a record low quarterly cash burn of $3.9 million [https://ir.butterflynetwork.com/News/press-releases/news-details/2025/Butterfly-Network-Reports-Third-Quarter-2025-Financial-Results/default.aspx].

Butterfly Network has also been active in fundraising, completing a public offering on January 31, 2025, which generated $81.7 million in net proceeds [https://ir.butterflynetwork.com/News/press-releases/news-details/2025/Butterfly-Network-Reports-First-Quarter-2025-Financial-Results/default.aspx]. This influx of capital contributed to a significant reduction in net loss and net cash used in operations during the first quarter of 2025. Earlier, in 2021, Butterfly Network finalized its business combination with Longview Acquisition Corp., leading to its listing on the NYSE [https://www.butterflynetwork.com/press-releases/butterfly-network-closes-business-combination-and-will-begin-trading-on-the-nyse]. At that time, the company announced unaudited 2020 full-year revenue of at least $45 million, exceeding prior forecasts and representing at least 63% growth [https://www.butterflynetwork.com/press-releases/butterfly-network-closes-business-combination-and-will-begin-trading-on-the-nyse].

The company has consistently demonstrated strong financial management by reaffirming its full-year revenue and adjusted EBITDA guidance across multiple quarters, indicating a stable and predictable financial outlook [https://ir.butterflynetwork.com/News/press-releases/news-details/2026/Butterfly-Network-Reports-First-Quarter-2026-Financial-Results/default.aspx]. Furthermore, strategic partnerships, such as the Midjourney collaboration, contributed $6.8 million in revenue during Q4 2025, significantly advancing the Butterfly Embedded™ platform strategy [https://ir.butterflynetwork.com/News/press-releases/news-details/2026/Butterfly-Network-Reports-Fourth-Quarter-2025-Financial-Results/default.aspx]. These financial milestones underscore Butterfly Network's trajectory as a leader in point-of-care ultrasound solutions.

Partnerships

Butterfly Network Partnerships, Clients and Vendors

Butterfly Network (butterflynetwork.com) has cultivated a robust ecosystem of partnerships and clients, establishing itself as a leader in point-of-care ultrasound (POCUS) solutions. The company collaborates with prominent healthcare institutions, including the Medical University of South Carolina and the University of Rochester Medical Center (URMC), to integrate its system-wide ultrasound platform, Butterfly Blueprint™, and deploy POCUS devices across their enterprises. A case study published in September 2024 highlighted the positive impact of URMC's transformative deployment of Butterfly's technology [https://www.butterflynetwork.com/press-releases/urmc-results]. Additionally, Atrium Health was an early adopter, becoming the first major health system in the nation to widely implement the Butterfly iQ for point-of-care ultrasound during the COVID-19 pandemic [https://www.butterflynetwork.com/press-releases/atrium-health-and-butterfly-network-drive-innovation-in-medical-imaging-during-covid-19-battle].

Butterfly Network also engages in strategic technology integrations and collaborations to expand its reach and capabilities. It has partnered with Ambra Health, an Intelerad Company, to enhance ultrasound data integration through a leading cloud-based medical image management suite [https://ir.butterflynetwork.com/News/press-releases/news-details/2022/Butterfly-Network-Announces-Partnership-With-Ambra-Health-to-Enhance-Ultrasound-Data-Integration/default.aspx]. Another significant partnership is with Sientra, aimed at improving diagnostic surveillance for breast implant patients by empowering surgeons with Butterfly's POCUS technology for screening and evaluation [https://www.butterflynetwork.com/press-releases/sientra-and-butterfly-network-announce-partnership]. The company's innovative spirit extends to a commercial agreement with Mendaera, marking the first Powered by Butterfly™ partnership to bring its Ultrasound-on-Chip™ technology to the robotic intervention market, anticipating revenue from each unit sold upon commercialization [https://www.butterflynetwork.com/press-releases/butterfly-mendaera-commercial-agreement].

Beyond direct healthcare providers and technology firms, Butterfly Network fosters broader ecosystem relationships. It has formed a landmark collaboration with the American College of Cardiology (ACC) to revolutionize cardiovascular care with ultrasound [https://www.butterflynetwork.com/press-releases/butterfly-acc]. The ACC emphasizes that

Events

Butterfly Network Event Participations

Butterfly Network (butterflynetwork.com) actively engages with the healthcare community through a diverse range of events, showcasing its commitment to advancing point-of-care ultrasound (POCUS). The company participates in prominent industry conferences such as the J.P. Morgan Healthcare Conference, the Evercore Healthcare Conference, the TD Cowen Annual Health Care Conference, and the William Blair Annual Growth Stock Conference, where its leadership often presents and hosts one-on-one meetings to discuss its groundbreaking Ultrasound-on-Chip™ technology and digital health solutions [https://ir.butterflynetwork.com/events-and-presentations/events/event-details/2025/43rd-Annual-JP-Morgan-Healthcare-Conference-Presentation/default.aspx]. These events are crucial for investor relations and for highlighting Butterfly Network's mission to democratize medical imaging globally [https://ir.butterflynetwork.com/overview/default.aspx].

Beyond investor-focused events, Butterfly Network hosts and features a robust webinar series designed for healthcare professionals [https://www.butterflynetwork.com/categories/webinars]. These educational sessions, often referred to as "POCUS Power Hour Webinars," cover various clinical settings and specialties, featuring expert-led, case-based discussions on topics like kidney health and lung ultrasound for intensivists [https://www.butterflynetwork.com/categories/webinars]. These webinars serve as a vital platform for doctors and other healthcare providers to learn how to integrate Butterfly Network's POCUS solutions, including its iQ3 and iQ+ probes, into their daily assessments, diagnoses, and treatments.

Butterfly Network also maintains a comprehensive Content Library on its website, offering a wealth of video and written materials that cover POCUS application and implementation [https://www.butterflynetwork.com/resources]. This resource provides further educational opportunities, supplementing its formal event participation and demonstrating the company's dedication to supporting its growing base of over 145,000 customers worldwide. Through these various event participations and educational initiatives, Butterfly Network reinforces its position as a leader in transforming patient care with its innovative handheld, whole-body ultrasound and intuitive software.

Frequently Asked Questions

What does Butterfly Network's recent hiring pattern suggest about their strategic focus?

Butterfly Network's recent executive appointments, such as Arun Nagdev as Chief Medical Officer – POCUS and David Horsley as SVP, Innovation – Butterfly Embedded™, indicate a strong strategic focus on advancing point-of-care ultrasound (POCUS) and developing embedded ultrasound technology. These hires, coupled with an open call for diverse talent from engineers to medical professionals, suggest a robust expansion phase centered on AI, workflow management software, and the 'Ultrasound-on-Chip™' technology.

Is Butterfly Network's financial trajectory a turnaround or a warning sign based on recent reports?

Butterfly Network's recent financial trajectory signals a consistent growth path rather than a warning sign. The company reported a 25% year-over-year revenue increase to $26.5 million in Q1 2026, building on a record $31.5 million in Q4 2025 with 41% year-over-year growth and positive net cash flow of $6.3 million. This performance, along with reaffirming full-year guidance and an $81.7 million public offering in 2025, suggests a stable and growing financial outlook, partly driven by strategic partnerships like the Midjourney collaboration.

What does Butterfly Network's engagement in industry events signify about its market strategy?

Butterfly Network's active participation in prominent industry conferences like J.P. Morgan Healthcare and Evercore, alongside its POCUS Power Hour Webinars and extensive Content Library, signifies a dual market strategy. It aims to strengthen investor relations and highlight its 'Ultrasound-on-Chip™' technology, while also actively educating healthcare professionals on integrating its iQ3 and iQ+ probes, reinforcing its mission to democratize medical imaging and support its 145,000+ customer base.

How do Butterfly Network's leadership appointments reflect its technological and market priorities?

Butterfly Network's leadership appointments, such as Joseph DeVivo as CEO and Chairman, and Victor Ku as SVP, Chief Technology Officer, reflect a strong emphasis on leveraging semiconductor-based ultrasound and AI-enabled analytics for digital health. The roles of Steve Cashman (EVP, Chief Business Officer) and John Soto (SVP, International) further highlight priorities in global sales expansion, product development, and market penetration, aligning with the company's mission to democratize medical imaging worldwide.

What do Butterfly Network's key partnerships, like with Mendaera and ACC, indicate about its future strategic direction?

Butterfly Network's partnerships with Mendaera for robotic intervention and the American College of Cardiology (ACC) indicate a strategic direction focused on expanding its 'Ultrasound-on-Chip™' technology beyond traditional POCUS and into specialized applications. The Mendaera agreement signals an entry into the robotic market, while the ACC collaboration underscores a commitment to integrating ultrasound into cardiovascular care, highlighting a move towards broader clinical and technological integration.

How does Butterfly Network's product and pricing model, including required memberships, differentiate it from competitors?

Butterfly Network's product and pricing model, featuring the iQ3 ($3,899) and iQ+ ($2,699) probes, is differentiated by its required annual Butterfly membership ($299 or $420). This subscription model unlocks full probe functionality, AI integration, and educational content, offering a comprehensive ecosystem rather than just hardware. This approach contrasts with alternatives like Suresult D3Ultra, which provides a no-subscription full-body option, positioning Butterfly Network for recurring revenue and continuous software/education engagement.

What is the core competitive advantage Butterfly Network emphasizes in the crowded POCUS market?

Butterfly Network's core competitive advantage in the POCUS market lies in its integrated ecosystem combining 'Ultrasound-on-Chip™' technology, advanced AI, workflow management software, and a comprehensive education suite. While competitors like Exo and Clarius offer portable devices, Butterfly Network emphasizes its single-probe, whole-body imaging capabilities and its mission to democratize medical imaging globally through accessible, affordable, and intelligently supported solutions.

What is the significance of Butterfly Network's development of a Software Development Kit (SDK) and an AI Marketplace?

The development of Butterfly Network's Software Development Kit (SDK) and an AI Marketplace signifies a strategic move to foster an open and extensible platform for its 'Ultrasound-on-Chip™' technology. This initiative aims to expand the 'Butterfly Garden' ecosystem by encouraging third-party developers to create custom applications and AI solutions, potentially driving broader adoption and new use cases for Butterfly Network's devices and data.

How does Butterfly Network's customer base of over 145,000 impact its competitive standing?

Butterfly Network's customer base of over 145,000 signifies substantial market penetration and a strong foundation in the POCUS sector. This large user base provides a significant competitive advantage through network effects, potential for recurring revenue from memberships, and valuable real-world data for AI and product development, elevating its standing against competitors like Exo, Clarius, and GE HealthCare.

What do the financial results for Q4 2025 and Q1 2026 indicate about Butterfly Network's operational efficiency?

The financial results for Q4 2025 and Q1 2026 indicate improving operational efficiency at Butterfly Network. Q4 2025 saw positive net cash flow of $6.3 million, a significant improvement. While Q1 2026 reported an adjusted EBITDA of ($6.1 million), the gross margin of 69% suggests strong unit economics. This, combined with a record low quarterly cash burn of $3.9 million in Q3 2025, points to a trend of better cost management and increasing financial discipline.

What is the primary value proposition Butterfly Network offers to healthcare professionals and systems?

Butterfly Network's primary value proposition to healthcare professionals and systems is the democratization of medical imaging through accessible, affordable, and high-quality point-of-care ultrasound. It offers handheld, whole-body ultrasound probes (iQ3, iQ+) integrated with advanced AI, workflow management software, and an extensive education suite. This empowers clinicians across various specialties to perform immediate assessments and diagnoses, transforming patient care by making sophisticated imaging more widely available.

Powered by ForesightIQ · Competitive intelligence from digital exhaust